tiprankstipranks
Akebia Therapeutics (AKBA)
NASDAQ:AKBA

Akebia Therapeutics (AKBA) Cash flow

1,049 Followers

Akebia Therapeutics Cash Flow

AKBA's free cash flow for Q4 2023 was $-2.31M. For the 2023 fiscal year, AKBA's free cash flow was decreased by $49.88M and operating cash flow was $-2.31M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -23.38M$ -23.38M$ -73.20M$ -252.97M$ -110.39M$ -257.44M
Investing Cash Flow
--$ -114.00K$ 39.94M$ -40.00M$ 211.18M
Financing Cash Flow
$ -25.21M$ -25.21M$ 14.60M$ 133.73M$ 231.72M$ 88.97M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 206.31M$ 44.58M$ 93.13M$ 151.82M$ 231.13M$ 149.80M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 6.06M$ 6.06M$ 6.75M$ 9.63M$ 7.84M-
Issuance Of Capital Stock
$ 6.79M$ 6.79M$ 7.53M$ 88.95M$ 209.42M$ 25.79M
Issuance Of Debt
$ -32.00M$ -32.00M$ -33.00M-$ 19.98M$ 77.67M
Repayment Of Debt
$ -32.00M$ -32.00M$ -33.00M-$ 0.00$ -15.00M
Free Cash Flow
$ -23.38M$ -23.38M$ -73.27M$ -253.02M$ -110.70M$ -264.10M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Akebia Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis